Objective
T1D, Diabetes
TYPE 1 DIABETES, DIABETES
Edited by: Giulio Romeo, Joslin Diabetes Center and Harvard Medical School, United StatesReviewed by: Sheyu Li, Sichuan University, China; Johannes Ferstad, Stanford University, United States; Neema Moraveji, Spire Health, United StatesThis article was submitted to Clinical Diabetes, a section of the journal Frontiers in EndocrinologyRemote patient monitoring (RPM) holds potential to enable more individualized and effective care for patients with type 1 diabetes (T1D), but requires population analytics to focus limited clinical resources on patients most in need. We explored the feasibility of RPM from patient and provider standpoints using a commercially available data analytic platform (